标题: |
中国儿童原发性免疫性血小板减少症诊断 与治疗改编指南(2021版) |
title: |
Adapted guideline for the diagnosis and treatment of primary immune thrombocytopenia for Chinese children (2021) |
版本: |
改编版 |
version: |
Adapted |
分类: |
标准指南 |
classification: |
Standard guideline |
领域: |
诊疗 |
field: |
Diagnosis and Treatment |
国家和地区: |
中国 |
Country and
region:
|
China |
指南使用者: |
各等级医院从事儿科疾病相关工作的临床医生、卫生决策人员和相关科研工作人员为本指南的使用人群。 |
Guide users:
|
Clinicians, health decision makers, and relevant research staff working on pediatric diseases in all levels of hospitals are the population to use this guideline. |
证据分级方法: |
GRADE |
Evidence grading
method:
|
GRADE |
制定单位: |
首都医科大学附属北京儿童医院 |
Formulating unit: |
Beijing Children′s Hospital |
注册时间: |
2024-04-08 |
Registration time: |
注册编号: |
IPGRP-2020CN077 |
Registration number: |
指南制订的目的: |
制订本指南旨在为中国儿童 ITP 的临床诊断和治疗提供循证依据,规范我国儿童 ITP临床诊疗决策,为临床实践提供证据支持。 |
Purpose of the guideline:
|
The purpose of this guideline is to provide an evidence-based basis for the clinical diagnosis and treatment of ITP in Chinese children, to standardize the clinical diagnosis and treatment decisions of ITP in Chinese children, and to provide evidence-based support for clinical practice. |